Health X Platform: Promoter Mittal Buys 5,000 Shares, Stake Up

TECH
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
Health X Platform: Promoter Mittal Buys 5,000 Shares, Stake Up
Overview

Health X Platform Limited reported that promoter Banwari Lal Mittal acquired 5,000 equity shares worth ₹13.77 lakh through market purchases. This transaction marginally increased his stake to 33.9238%, signaling continued promoter confidence in the digital healthcare firm. The move complies with SEBI insider trading norms.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Promoter Banwari Lal Mittal Increases Stake in Health X Platform

Promoter Banwari Lal Mittal has acquired 5,000 equity shares of Health X Platform Limited for ₹13,76,899.75. This purchase increases his stake in the digital healthcare company to 33.9238%.

Transaction Details

Health X Platform Limited announced its promoter, Banwari Lal Mittal, purchased 5,000 company shares via market transactions on March 30, 2026. The total value of this acquisition was ₹13,76,899.75. Following the purchase, Mr. Mittal's holding rose from 33.9081% to 33.9238%. This disclosure, made on March 31, 2026, adheres to SEBI insider trading regulations.

Significance of the Purchase

Promoter share purchases are often seen by investors as a strong sign of confidence in a company's future prospects. Even a minor increase in ownership by a key insider can be viewed positively. This recent transaction further shows the promoter's ongoing commitment to Health X Platform Limited.

Company Background

Health X Platform Limited, previously known as Sastasundar Ventures Limited, operates an Indian digital healthcare network. The company focuses on managing a pharma supply chain and connecting healthcare services like doctors, diagnostics, and health information through its online platforms. Promoter Banwari Lal Mittal serves as Chairman and Managing Director.

What This Means for Ownership

Banwari Lal Mittal's shareholding in Health X Platform Limited has seen a small increase. His total stake now represents 33.9238% of the company's equity. The transaction is unlikely to significantly alter the overall public float.

Risks Noted

The recent company filing did not identify specific risks directly related to this promoter share purchase.

Competitive Landscape

Health X Platform operates in India's growing digital health and health-tech market, competing with several key players. These include Tata 1mg, Practo, PharmEasy (API Holdings), and MediBuddy, all of which offer similar online pharmacy, diagnostics, and telehealth services. These companies are actively using technology to improve healthcare access across India.

Shareholding Details

As of March 30, 2026, Banwari Lal Mittal held 1,07,91,355 equity shares, representing 33.9238% of the company's capital. Before this purchase on March 30, 2026, his holding was 1,07,86,355 equity shares, or 33.9081% of the capital.

What to Monitor Next

Investors will likely watch for further stake adjustments by promoters or major shareholders. Also relevant are Health X Platform Limited's upcoming quarterly financial results, operational updates, and its overall performance and growth within the competitive digital health market. Any strategic announcements from the company will also be of interest.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.